🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Hormonal Management of Heavy Menstrual Bleeding in Adolescents

Recruitingn/aAges any - 25 YearsFemaleUniversity Hospital, Geneva
NCT06740929 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this study is to evaluate whether hormonal medications (such as contraceptive pill, patch, injectable progestins and hormonal intra-uterine device) have similar efficacy at managing heavy menstrual bleeding in adolescents with a bleeding disorder compared to those without. We also aim to assess the quality of life and hemoglobin and iron levels in this population.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Adolescents and young adults aged \< 26yo * Presenting to the gynecology consultation at HUG * Diagnosed with heavy menstrual bleeding (PBAC \> 100) * Willing to initiate a hormonal medication to manage heavy menstrual bleeding Exclusion Criteria: * Pregnancy or planning to become pregnant during the study period * Already using hormonal medication for menstrual management and/or contraception * Known anatomical uterine pathology * Using anticoagulant or antiaggregant agents
💊

What it tests

  • Not listed
📍

Where

1 site
Geneva University Hospitals
Geneva, Switzerland
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy